Home / Blood Tests / Activated Partial Thromboplastin Time (aPTT)

Activated Partial Thromboplastin Time (aPTT)

The Activated Partial Thromboplastin Time (aPTT) test measures how long it takes for blood to clot. It evaluates the function of specific proteins in the blood, known as clotting factors, which are part of the body’s coagulation process. This test is essential for diagnosing bleeding disorders, monitoring conditions that affect clotting, and managing patients on blood-thinning therapies like heparin. Indications for testing - Unexplained bleeding or bruising: To investigate potential bleeding disorders. - Prolonged clotting time: If blood takes an unusually long time to clot after injury. - Before surgery: To check for any clotting abnormalities that could pose risks during or after the procedure. - Monitoring heparin therapy: To ensure the correct dosage of heparin is administered without causing excessive bleeding or clot formation. - Diagnosis of clotting disorders: Such as hemophilia, von Willebrand disease, or antiphospholipid syndrome. - Liver disease assessment: Since the liver produces many clotting factors, aPTT can help evaluate liver function. Fasting requirements No fasting required for an aPTT test. However, certain medications, such as blood thinners or aspirin, can affect the test results. It is essential to inform your healthcare provider about any medications or supplements you are taking before the test. What can be detected - Clotting factor deficiencies: Including hemophilia A or B, which result in a longer clotting time. - Bleeding disorders: Such as von Willebrand disease, where the blood doesn't clot properly. - Liver dysfunction: Since the liver is involved in producing clotting factors, impaired liver function may prolong aPTT. - Heparin overdose or underdose: Monitoring patients on heparin therapy to prevent complications from incorrect dosing. - Antiphospholipid syndrome: A condition that can lead to blood clots in veins and arteries, causing a prolonged aPTT. The aPTT test is a valuable tool in diagnosing and managing bleeding and clotting disorders. It is frequently used to monitor anticoagulant therapy, ensuring patients receive the right dose of heparin to prevent blood clots without increasing the risk of bleeding. Additionally, it helps in diagnosing conditions related to clotting factor deficiencies, liver disease, and autoimmune disorders like antiphospholipid syndrome. Checking this marker allows for early detection and more effective treatment, improving patient outcomes in conditions related to abnormal blood clotting. For patients undergoing surgery, starting anticoagulant therapy, or with unexplained bleeding issues, an aPTT test provides essential information for safe and effective care.

There is an additional £20 phlebotomy fee for every donation.